Basics Pliant Therapeutics, Inc. IPO Date: June 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $74.35M Activated in VL: True Average Daily Range Avg Daily Range: $0.53 | 3.21% Avg Daily Range (30 D): $0.05 | 3.42% Avg Daily Range (90 D): $0.06 | 3.65% Institutional Daily Volume Avg Daily Volume: .54M Avg Daily Volume (30 D): 1.29M Avg Daily Volume (90 D): .92M Trade Size Avg Trade Size (Sh.): 97 Avg Trade Size (Sh.) (30 D): 253 Avg Trade Size (Sh.) (90 D): 224 Institutional Trades Total Inst.Trades: 1,076 Avg Inst. Trade: $1.51M Avg Inst. Trade (30 D): $.82M Avg Inst. Trade (90 D): $1.39M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.58M Avg Closing Trade (30 D): $.71M Avg Closing Trade (90 D): $.71M Avg Closing Volume: 101.7K     News Mar 23, 2025 @ 12:34 PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates ... Source: N/A Feb 7, 2025 @ 9:58 PM Pliant Therapeutics Provides Update on BEACON-IPF,... Source: N/A Nov 18, 2024 @ 11:00 PM Pliant Therapeutics Presents Data from its Bexoteg... Source: N/A Jul 13, 2024 @ 1:35 AM Pliant Therapeutics CBO sells shares worth over $1... Source: Investing.Com May 7, 2024 @ 3:53 PM These Analysts Revise Their Forecasts On Pliant Th... Source: Avi Kapoor Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.43 $-.71 Diluted EPS $-.43 $-.71 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -26.3M $ -43.3M Operating Income / Loss $ $ -28.27M $ -45.59M Cost of Revenue $ $ $ Net Cash Flow $ $ 6.91M $ -5.12M PE Ratio